1.上海中医药大学附属岳阳中西医结合医院,上海市虹口区甘河路110号,200437
2.复旦大学附属中山医院
3.上海市针灸经络研究所
195641459@qq.com
收稿:2021-11-23,
修回:2022-05-30,
纸质出版:2023-03-02
移动端阅览
沙珊焱,李思雨,朱玮等.中药温肾升白方结合艾灸治疗乳腺癌蒽环类药物化疗患者白细胞减少症34例临床观察[J].中医杂志,2023,64(05):482-489.
SHA Shanyan,LI Siyu,ZHU Wei,et al.Clinical Observation on Wenshen Shengbai Formula (温肾升白方) Combined with Moxibusiton in Improving Anthracycline Chemotherapy-induced Leukopenia in 34 Cases of Breast Cancer[J].Journal of Traditional Chinese Medicine,2023,64(05):482-489.
沙珊焱,李思雨,朱玮等.中药温肾升白方结合艾灸治疗乳腺癌蒽环类药物化疗患者白细胞减少症34例临床观察[J].中医杂志,2023,64(05):482-489. DOI: 10.13288/j.11-2166/r.2023.05.010.
SHA Shanyan,LI Siyu,ZHU Wei,et al.Clinical Observation on Wenshen Shengbai Formula (温肾升白方) Combined with Moxibusiton in Improving Anthracycline Chemotherapy-induced Leukopenia in 34 Cases of Breast Cancer[J].Journal of Traditional Chinese Medicine,2023,64(05):482-489. DOI: 10.13288/j.11-2166/r.2023.05.010.
目的
2
探讨温肾升白方结合艾灸在改善乳腺癌蒽环类药物化疗所致白细胞减少症的作用。
方法
2
纳入计划使用蒽环类药物化疗、中医辨证为气血两亏证兼肝肾阴虚证的乳腺癌患者105例,采用分层随机(区组)分组方法分为对照组、艾灸组及灸药组各35例。各组均给予蒽环类药物化疗,对照组不给予任何中医药治疗。艾灸组予艾灸治疗,化疗当天不艾灸,每个化疗周期第2天开始,连续灸13天,每个穴位每次灸15 min,每日2次;同时口服安慰剂中药,每次化疗结束后,避开胃肠道反应急性期(一般为化疗后5~7天)开始服用,每日1剂,连续服用2周。灸药组给予温肾升白方口服(服用方法同安慰剂中药),并结合艾灸治疗(方法同艾灸组)。各组均观察4个化疗周期,记录患者白细胞(WBC)计数、中性粒细胞(ANC)绝对值的最低值,以及注射重组人粒细胞集落刺激因子注射液(rhG-CSF)的使用剂量,并监测其肝肾功能、心电图、乳酸脱氢酶、肌酸肌酶、肌酸激酶同工酶等安全性指标。
结果
2
与本组治疗前比较,各组患者4个化疗周期的WBC计数、ANC计数均降低(
P
<0.05)。与对照组比较,艾灸组在第3、4化疗周期的WBC计数、ANC计数均升高,灸药组4个周期的WBC计数、ANC计数亦升高(
P
<0.05)。与艾灸组比较,灸药组4个周期的WBC计数,第1、2、4周期的ANC计数均升高(
P
<0.05)。艾灸组、灸药组在各化疗周期的rhG-CSF使用剂量均低于对照组(
P
<0.05),但两组比较差异无统计学意义(
P
>0.05)。各组安全性指标比较差异无统计学意义(
P
>0.05)。
结论
2
艾灸或温肾升白方联合艾灸均可改善化疗性白细胞减少症,减少rhG-CSF使用剂量,且安全性较好。
Objective
2
To investigate the effect of
Wenshen Shengbai Formula
(温肾升白方, WSF) combined with moxibustion in improving leukopenia induced by anthracycline chemotherapy for breast cancer patients.
Methods
2
A total of 105 breast cancer patients with
qi
and blood depletion syndrome and liver and kidney
yin
deficiency syndrome who were about to receive anthracycline chemotherapy were randomized into control group, moxibustion group and moxibustion+WSF group by stratified (block) randomization, with 35 patients in each group. During anthracycline chemotherapy for all groups, the control group was not given any traditional Chinese medicine treatment. The moxibustion group was given moxibustion treatment from the 2rd day of each chemotherapy cycle for 13 days; the moxibustion time at each acupoint was 15min, twice daily; simultaneously, placebo of WSF was orally taken after chemotherapy but avoiding the acute phase of gastrointestinal reactions (usually 5 to 7 days after chemotherapy), one dose daily for 2 consecutive weeks. The moxibustion+WSF group was given WSF with the same administration method of placeo, and moxibustion with the same method used in the moxibustion group. After four cycles of chemotherapy, the lowest white blood cell (WBC) count and absolute neutrophil count (ANC) were recorded, as well as the dosage of recombinant human granulocyte colony-stimulating factor injection (rhG-CSF), and the safety indicators including liver and kidney function, electrocardiogram, lactate dehydrogenase, creatine creatine enzyme, creatine kinase isoenzyme were observed.
Results
2
After chemotherapy, the WBC and ANC counts in each of the four cycles were significantly reduced (
P
<0.05). Compared to those in the control group, the WBC and ANC counts in the moxibustion group increased in the 3rd and 4th chemotherapy cycles, as well as those of all four chemotherapy cycles in the moxibustion+WSF group (
P
<0.05). Compared to those in the moxibustion group, the WBC counts of the four cycles and the ANC counts of the 1st, 2nd, and 4th cycles in the moxibustion+WSF group all increased (
P
<0.05). The dosage of rhG-CSF in the moxibustion group and the moxibustion+WSF group in all chemotherapy cycles were significantly lower than that in the control group (
P
<0.05), but there was no significant difference between the two groups (
P
>0.05). There was no significant difference in the safety indicators among the groups (
P
>0.05).
Conclusion
2
Moxibustion alone or in combination with WSF can improve chemotherapy-induced leukopenia, reduce the dosage of rhG-CSF with safty.
SUNG H , FERLAY J , SIEGEL RL , et al . Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .
张敏璐 , 彭鹏 , 吴春晓 , 等 . 2008-2012年中国肿瘤登记地区女性乳腺癌发病和死亡分析 [J]. 中华肿瘤杂志 , 2019 , 41 ( 4 ): 315 - 320 .
陆清 , 赵磊 , 江科 , 等 . 温肾升白方防治乳腺癌术后化疗致白细胞减少症的临床观察 [J]. 上海中医药大学学报 , 2014 , 28 ( 3 ): 29 - 31, 46 .
JI Y , LI S , ZHANG X , et al . The efficacy of moxibustion for breast cancer patients with chemotherapy-induced myelosuppression during adjuvant chemotherapy: a randomized controlled study [J]. Evid Based Complement Alternat Med , 2021 , 2021 ( 4 ): 1347342 .
JI Y , LI S , ZHANG X , et al . The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer:study protocol for a randomized controlled trial [J]. Trials , 2020 , 21 ( 1 ): 844 - 855 .
邵志敏 , 沈镇宙 , 徐兵河 . 乳腺肿瘤学 [M]. 2版 . 上海 : 复旦大学出版社 , 2018 : 129 - 178 .
TAN PH , ELLIS IO . Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012 [J] . J Clin Pathol , 2013 , 66 ( 6 ): 465 - 470 .
AMIN MB , EDGE SB , GREENE FL , et al . AJCC cancer staging manual [M]. 8th ed . New York : Springer , 2017 : 27 - 32 .
陆德铭 , 陆金根 . 实用中医外科学 [M]. 2版 . 上海 : 上海科学技术出版社 , 2010 : 172 - 177 .
中华中医药学会 . 肿瘤中医诊疗指南 [M]. 北京 : 中国中医药出版社 , 2008 : 13 - 14 .
肖献辉 , 贾润苗 , 李红珂 , 等 . 艾灸足三里穴位治疗广泛期小细胞肺癌化疗后骨髓抑制疗效观察 [J]. 中医药临床杂志 , 2019 , 31 ( 2 ): 339 - 342 .
GRADISHAR WJ , MORAN MS , ABRAHAM J , et al . NCCN Guidelines ® insights: breast cancer, version 4. 2021 [J]. J Natl Compr Canc Netw , 2021 , 19 ( 5 ): 484 - 493 .
梁繁荣 , 王华 . 针灸学 [M]. 4版 . 北京 : 中国中医药出版社 , 2016 : 147 .
李丹 . 针刺联合5-HT受体拮抗剂对乳腺癌化疗急性胃肠道反应的影响 [D]. 广州 : 广州中医药大学 , 2017 .
TRAN D , ROHAN M , RAKSHA B , et al . The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis [J] . Breast Cancer Res Treat , 2015 , 153 ( 3 ): 591 - 597 .
余志红 , 陈嘉斌 , 徐国暑 , 等 . 柴可群运用中医辨治肿瘤四则四法论治肝癌经验 [J]. 中医杂志 , 2019 , 60 ( 7 ): 559 - 561 .
陈红风 , 秦国政 , 陈明岭 , 等 . 中医外科学 [M]. 2版 . 北京 : 人民卫生出版社 , 2002 : 139 - 140 .
佚名 . 注重冲任、擅治乳病的外科专家:陆德铭 [J]. 上海中医药杂志 , 1997 ( 3 ): 37 - 38 .
季亚婕 , 唐菁 , 陈玮黎 , 等 . 辅助化疗对乳腺癌患者中医体质的影响及“乳癌术后方”的调节作用 [J]. 上海中医药大学学报 , 2016 , 30 ( 1 ): 11 - 14 .
盛佳钰 , 张馨月 , 李琼 , 等 . 基于肿瘤微环境中TLR4/NF-κB通路的变化探讨乳癌术后方对乳腺癌小鼠肺转移的影响 [J]. 中华中医药学刊 , 2016 , 34 ( 12 ): 2864 - 2867 .
瞿文超 , 吴雪卿 , 冯佳梅 , 等 . 中药复方对不同分子分型乳腺癌患者无病生存率及总生存率的影响 [J]. 中医药学报 , 2017 , 45 ( 6 ): 92 - 95 .
廖大忠 . 黄芪多糖诱导淋巴细胞增殖及肿瘤细胞杀伤作用的研究 [J]. 四川中医 , 2019 , 37 ( 11 ): 58 - 60 .
张红梅 , 范颖 , 林庶茹 . 黄芪不同有效部位配伍对骨髓抑制模型小鼠粒系调控因子的影响 [J]. 中国实验方剂学杂志 , 2011 , 17 ( 22 ): 134 - 137 .
薄芯 , 董历平 , 屠蘅菁 . 黄精、党参和绿茶减轻环磷酰胺毒副反应初探 [J]. 中医研究 , 1997 , 10 ( 3 ): 22 - 24 .
张明发 , 沈雅琴 . 苦参碱类生物碱免疫促进作用的研究进展 [J]. 药物评价研究 , 2019 , 42 ( 3 ): 579 - 585 .
李晶 , 李娜 , 律广富 , 等 . 鹿角胶对环磷酰胺所致血虚模型小鼠的影响 [J]. 吉林中医药 , 2014 , 34 ( 10 ): 973 - 975 .
曹胜男 , 包海鹰 . 鹿角的化学成分及药理活性研究进展 [J]. 经济动物学报 , 2011 , 15 ( 4 ): 230 - 233 .
吴焕淦 . 中国灸法学现代研究 [M]. 上海 : 上海科学技术出版社 , 2013 : 544 - 552 .
雷菲 , 赵继梦 , 吴焕淦 , 等 . 针灸联合止吐剂防治化疗相关性恶心呕吐临床研究进展 [J]. 亚太传统医药 , 2016 , 12 ( 11 ): 57 - 60 .
翁志军 , 王立东 , 季亚婕 , 等 . NMDA受体NR2B亚基在慢性内脏痛敏及针灸治疗中的作用 [J]. 世界中医药 , 2016 , 11 ( 6 ): 1114 - 1118 .
LIN YY , ZHAO JM , JI YJ , et al . Typical ulcerative colitis treated by herbs-partitioned moxibustion: a case report [J]. World J Clin Cases , 2020 , 8 ( 8 ): 1515 - 1524 .
季亚婕 , 李思雨 , 吴焕淦 , 等 . 化疗对乳腺癌患者中医体质的影响及艾灸的调节作用 [J]. 世界中西医结合杂志 , 2020 , 15 ( 4 ): 735 - 741 .
崔云华 , 冯静 , 吴焕淦 , 等 . 隔药饼灸治疗脾肾阳虚型桥本甲状腺炎的疗效观察 [J]. 上海针灸杂志 , 2020 , 39 ( 12 ): 1483 - 1490 .
路玫 , 曹大明 , 赵喜新 , 等 . 针灸对环磷酰胺所致骨髓抑制小鼠骨髓细胞周期调节蛋白Cyclin D1表达及细胞周期的动态影响 [J]. 中国中西医结合杂志 , 2011 , 31 ( 2 ): 238 - 243 .
0
浏览量
0
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号